High- and intermediate-methylation epigenotypes strongly correlated with BRAF and KRAS mutations, respectively, and low-methylation epigenotype correlated with the absence of these oncogene mutations, suggesting the existence of at least three distinct pathways in the genesis of CRC. The gene discussed is KRAS; the disease is colorectal carcinoma.